Severe agranulocytosis following first infliximab infusion in Crohn's disease
✍ Scribed by José Miguel Rosales-Zábal; Francisco Fernández-Pérez; Cristóbal Albandea-Moreno; Francisco Miguel Vera-Rivero; José María Navarro-Jarabo
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 217 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
✦ Synopsis
FIGURE 2. Granulocyte count during hospitalization. IFX: infliximab infusion. GR-CSF: introduction of granulocyte stimulating factor.
📜 SIMILAR VOLUMES
## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea
## Background: The efficacy of infliximab as maintenance therapy in patients with otherwise chronically active crohn's disease (cd) is well established. data concerning the linear growth response are sparse and can only be accrued in children. ## Methods: From september 2000 to february 2004, 32